Charlotte Kirby Charlotte Kirby

Rovco secures contract for Green Volt floater

Rovco has been awarded the site characterisation operations for the Green Volt floating offshore wind farm, situated 80 km east of Peterhead, Scotland. Slated to be fully operational by 2029, Green Volt is poised to become one of the world's largest floating offshore wind farms.

Read More
Charlotte Kirby Charlotte Kirby

Oxford Drug Design makes key appointment

Oxford Drug Design, an Oxford-based AI drug discovery company and pioneer in AI therapeutic innovation, has appointed leading oncologist and academic Professor Sarah Blagden to its Scientific Advisory Board.

Read More
Charlotte Kirby Charlotte Kirby

Barcode-Less Product Scanners

SeeChange Technologies, a company known for its retail-focused computer vision AI technology, has announced a strategic partnership with Diebold Nixdorf, a global leader in retail consumer and staff journey solutions, to introduce an innovative series of AI-powered self-checkout solutions.

Read More
Charlotte Kirby Charlotte Kirby

Cambridge Nutraceuticals builds brand portfolio with acquisition of GP Nutrition

Cambridge Nutraceuticals, the parent company of science-backed nutritional food supplement brands, FutureYou Cambridge and Prime Fifty, has expanded its brand portfolio with the acquisition of GP Nutrition. GP Nutrition was founded by leading nutritionist and double Sunday Times bestselling author, Gabriela Peacock.

Read More
Charlotte Kirby Charlotte Kirby

Psyomics secures £4M to revolutionise mental health assessment with AI

Psyomics, a UK-based mental health technology company, has secured £4 million in fresh funding. Parkwalk Advisors (which invested in adsilico and Oxford Endovascular) the UK’s most active investor in university spinouts, led the funding round by investing a further £3.5 million.

Read More
Charlotte Kirby Charlotte Kirby

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect®PLUS. In conjunction with the Company’s Cyto-Mine® platform, the new assay provides a streamlined method to measure antibody production in single cells by rapidly detecting secreted human IgG, enabling the identification and selection of cells with the highest productivity for more efficient cell line development.

Read More